BioNTech faces first German vaccine lawsuit amid claims of side effects
BioNTech is scheduled to make an appearance in a court in Hamburg today in response to a lawsuit that was filed by a German woman. The woman claims that she experienced side effects from the company’s Covid-19 vaccine and is seeking 5.6 million baht (US$160,000) in damages. This is the first time that BioNTech has been sued in Germany in connection with a vaccine-related case.
The plaintiff asserts that after receiving the vaccine, she suffered from a variety of physical side effects, including pain in the upper body, swelling in the limbs, fatigue, and disturbed sleep patterns. On the other hand, according to German law, drug or vaccine manufacturers are obligated to pay damages if there is medical evidence indicating that their products caused excessive harm in comparison to the benefits, or if there is incorrect information on the label.
BioNTech maintains that the case is without foundation and reaffirms that the company’s Covid vaccine, which is marketed under the brand name Comirnaty, has been shown to be both safe and effective in clinical trials. More than 1.5 billion people around the world and more than 64 million people in Germany have already been vaccinated against the disease.
The European Medicines Agency (EMA) has stated that the Comirnaty vaccine that is manufactured by BioNTech is one of the vaccines that is most commonly used in the Western Hemisphere and that it is safe to use. The European Medicines Agency (EMA) reaffirmed the benefits of the vaccine and the very low risk of developing myocarditis associated with using it last week.
